Gordon MJ, Feng L, Strati P, Lee HJ, et al. Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study. Cancer 2023 Nov 20. doi: 10.1002/cncr.35114.
PMID: 37985359